Andrea C. King to Tobacco Use Disorder
This is a "connection" page, showing publications Andrea C. King has written about Tobacco Use Disorder.
Connection Strength
2.092
-
Evaluation of a Randomized Clinical Trial Comparing the Effectiveness of a Culturally Targeted and Nontargeted Smoking Cessation Intervention for Lesbian, Gay, Bisexual, and Transgender Smokers. Nicotine Tob Res. 2019 10 26; 21(11):1506-1516.
Score: 0.660
-
Genetic ancestry as an effect modifier of naltrexone in smoking cessation among African Americans: an analysis of a randomized controlled trial. Pharmacogenet Genomics. 2015 Jun; 25(6):305-12.
Score: 0.486
-
Effects of naltrexone on smoking cessation outcomes and weight gain in nicotine-dependent men and women. J Clin Psychopharmacol. 2012 Oct; 32(5):630-6.
Score: 0.404
-
Tobacco chippers show robust increases in smoking urge after alcohol consumption. Psychopharmacology (Berl). 2007 Feb; 190(3):321-9.
Score: 0.262
-
Naltrexone alteration of acute smoking response in nicotine-dependent subjects. Pharmacol Biochem Behav. 2000 Jul; 66(3):563-72.
Score: 0.173
-
A pilot community-based intensive smoking cessation intervention in African Americans: feasibility, acceptability and early outcome indicators. J Natl Med Assoc. 2008 Feb; 100(2):208-17.
Score: 0.073
-
Intranasal oxytocin dampens cue-elicited cigarette craving in daily smokers: a pilot study. Behav Pharmacol. 2016 12; 27(8):697-703.
Score: 0.034